Lord, Abbett & Co’s Allergan Inc AGN Stock Holding History

Lord, Abbett & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-81,607	Closed	-$10.1M	–	1131
2014 Q1	$10.1M	Buy	+81,607	New	+$9.94M	0.02%	634

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lord, Abbett & Co's AGN Position: Q2 2014 in Review

Lord, Abbett & Co sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 81,607 shares — an estimated $10.1M sold.

Lord, Abbett & Co first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $10.1M in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Lord, Abbett & Co reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
Lord, Abbett & Co sold 81,607 Allergan Inc shares in Q2 2014, an estimated $10.1M.
Lord, Abbett & Co first reported a position in Allergan Inc in Q1 2014 and held it in 1 quarter.
Lord, Abbett & Co's Allergan Inc position peaked at $10.1M in Q1 2014.
770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Lord, Abbett & Co's 13F filing for Q2 2014, filed 14 Aug 2014.